Market Cap (In KRW)
122.65 Billion
Revenue (In KRW)
794.71 Billion
Net Income (In KRW)
-16.24 Billion
Avg. Volume
42.01 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7200.0-12380.0
- PE
- -
- EPS
- -
- Beta Value
- 1.162
- ISIN
- KR7002620003
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Seung-Soo Han
- Employee Count
- -
- Website
- https://www.jeilpharm.co.kr
- Ipo Date
- 2000-01-04
- Details
- Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.
More Stocks
-
AMLLFAEON Mall Co., Ltd.
AMLLF
-
RISHABHRishabh Instruments Limited
RISHABH
-
EICCFE Automotive Inc.
EICCF
-
SMIZF
-
WXIBF
-
JLHL
-
1033
-
002926HUAXI Securities Co., Ltd.
002926